Close

Analyst Ratings for Biohaven Pharmaceutical Holding (BHVN) [Buys]

BHVN Rating Summary

BHVN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BHVN
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $59.38 (+77.7%) * Over Last 12-Mos
Rating Score: 7.8 / 10   Percentile Rank: 83%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/16/2024 RBC Capital
» Updated 5/29/2024
Leonid Timashev New Coverage Outperform
(N/A)
59.00
(N/A)
49.11
(33.41)
-31.97% Details
2/6/2024 UBS
» Updated 4/23/2024
Ashwani Verma New Coverage Buy
(N/A)
60.00
(59.00)
44.79
(33.41)
-25.41% Details